In a 57-year-old male smoker with macrocytic anemia (MCV 127 fL), leukopenia (WBC 3.4 ×10⁹/L), hemoglobin 10.2 g/dL, hematocrit 28.9 %, platelets 159 ×10⁹/L, and normal thyroid function, what is the most likely diagnosis and what initial workup and management steps should be taken?

Macrocytic Anemia with Pancytopenia: Urgent Evaluation for Myelodysplastic Syndrome

This 57-year-old male smoker with severe macrocytic anemia (MCV 127 fL), pancytopenia, and normal thyroid function requires immediate peripheral blood smear review and bone marrow biopsy to rule out myelodysplastic syndrome (MDS), which is the most concerning diagnosis given his smoking history, age, and degree of macrocytosis.

Clinical Reasoning

The combination of findings is highly concerning:

• Severe macrocytosis (MCV 127.3 fL): Values >110 fL significantly increase the likelihood of megaloblastic anemia, but also raise concern for MDS 1
• Pancytopenia: WBC 3.4, platelets 159 (borderline low), and severe anemia (Hgb 10.2) suggest bone marrow dysfunction rather than isolated nutritional deficiency 2
• Smoking history: Major risk factor for MDS and other hematologic malignancies
• Normal thyroid function: Excludes hypothyroidism as a cause

Immediate Diagnostic Workup

First-Line Essential Tests 3:

1. Peripheral blood smear review - Critical to identify:

   • Hypersegmented neutrophils (megaloblastic anemia)
   • Dysplastic features (MDS)
   • Blast cells
   • Red cell morphology

2. Reticulocyte count/index - Distinguishes production vs. destruction:

   • Low reticulocyte index (<2.0) indicates decreased RBC production, suggesting vitamin deficiency, aplastic anemia, or bone marrow dysfunction 1
   • High reticulocyte index suggests hemolysis or bleeding (less likely here)

3. Vitamin B12 and folate levels - Most common reversible causes of macrocytic anemia 1, 3

4. Serum ferritin and transferrin saturation - To assess iron stores 3

5. LDH, haptoglobin, indirect bilirubin - To exclude hemolysis 1

6. Comprehensive metabolic panel - Including creatinine to exclude renal anemia 1

Second-Line Critical Tests:

1. Bone marrow aspirate and biopsy with cytogenetics - Mandatory if:
   • Vitamin B12/folate levels are normal or only mildly reduced
   • No response to vitamin replacement within 1-2 weeks
   • Peripheral smear shows dysplastic features or blasts
   • Unexplained persistent pancytopenia 2

Most Likely Diagnoses (in order of concern):

1. Myelodysplastic Syndrome (MDS) - Highest concern

• Smoking is a risk factor
• Age 57 years (typical demographic)
• Pancytopenia with macrocytic anemia is classic presentation 2
• MDS commonly presents with macrocytic anemia (often >100 fL) 1, 2
• Critical caveat: Three patients with megaloblastic marrow who failed vitamin replacement were ultimately diagnosed with MDS 4

2. Vitamin B12 Deficiency

• Most common cause of megaloblastic macrocytic anemia (78.3% in one series) 4
• Can occur in non-vegetarians (73.9% in one study) 4
• Smoking may impair B12 absorption
• However: Isolated B12 deficiency rarely causes significant leukopenia

3. Combined B12 and Folate Deficiency

• Accounts for 21.7% of megaloblastic cases 4
• Smoking and poor nutrition are risk factors

4. Alcohol-Related Macrocytosis

• Must specifically ask about alcohol consumption
• Can cause macrocytosis even without liver disease 1, 3
• Often associated with folate deficiency 5

Management Algorithm

Step 1: Immediate Actions

• Check B12 and folate levels TODAY
• Order peripheral blood smear review by hematopathologist
• Obtain reticulocyte count

Step 2: Based on Initial Results

If B12 <200 pg/mL or folate <2 ng/mL:

• Start replacement therapy:
  • Cyanocobalamin 1000 mcg IM daily × 7 days, then weekly 5
  • Folic acid 1-5 mg PO daily
• Recheck CBC in 7-10 days: Expect reticulocyte response within 3-5 days if nutritional deficiency
• If no improvement by 2 weeks: Proceed to bone marrow biopsy 4

If B12 and folate are normal or high-normal:

• Proceed directly to bone marrow biopsy - do not delay 2
• High suspicion for MDS or other primary bone marrow disorder

If peripheral smear shows:

• Dysplastic features or blasts: Urgent hematology referral and bone marrow biopsy 2
• Only hypersegmented neutrophils: Consider therapeutic trial of vitamins with close follow-up

Step 3: Bone Marrow Evaluation (if indicated)

Must include 2:

• Aspirate with morphology (evaluate for dysplasia, blast count)
• Core biopsy with histology
• Cytogenetics (karyotype)
• Consider flow cytometry if MDS suspected

Critical Pitfalls to Avoid

1. Do not assume nutritional deficiency without confirmation: The pancytopenia and smoking history make MDS a serious concern 2

2. Do not delay bone marrow biopsy if vitamins are normal: Median time to MDS diagnosis in unexplained macrocytosis is 31.6 months; early diagnosis improves outcomes 6

3. Do not miss alcohol history: Specifically ask about quantity and frequency; alcohol causes macrocytosis independent of nutritional deficiency 3, 7

4. Do not ignore the leukopenia: Isolated B12 deficiency rarely causes WBC 3.4; this suggests broader bone marrow dysfunction 2

5. Do not treat empirically without follow-up: If starting vitamins, recheck CBC in 7-10 days to confirm response 4

Prognosis Considerations

• If MDS: Prognosis depends on IPSS-R score (blast percentage, cytopenias, cytogenetics) 2
• If vitamin deficiency: Excellent prognosis with replacement therapy
• Unexplained macrocytosis: 11.6% develop primary bone marrow disorder over 4 years; requires monitoring every 6 months 6

Given the severity of findings and smoking history, hematology consultation should be obtained within 1-2 weeks regardless of initial vitamin levels 3, 2.